Learn languages naturally with fresh, real content!

tap to translate recording

Explore By Region

flag Gilead and Global Fund to supply new HIV drug, lenacapavir, to low-income countries at cost.

flag Gilead Sciences and the Global Fund have agreed to supply the new HIV prevention drug, lenacapavir, to low-income countries. flag Approved in the U.S., this twice-yearly injection can reduce HIV transmission risk by over 99.9%. flag Gilead will provide the drug at cost to reach up to 2 million people over three years. flag The World Health Organization is reviewing it, and the first shipments are expected to reach Africa by the end of the year.

44 Articles